Talisman Wealth Advisors LLC Pfizer Inc Transaction History

Talisman Wealth Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $22,315 - $28,984	-854 Reduced 10.19%	7,523 $216,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $37,320 - $43,624	-1,163 Reduced 12.19%	8,377 $277,000
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $18,565 - $21,480	514 Added 5.69%	9,540 $349,000
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $22,570 - $29,383	573 Added 6.78%	9,026 $368,000
Q4 2022 Feb 15, 2023	BUY	$41.75 - $54.5 $352,912 - $460,688	8,453 New	8,453 $433,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Talisman Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Talisman Wealth Advisors LLC with notifications on news.